Energenesis Biomedical Co., Ltd. (6657)

Overview

Energenesis Biomedical CO.,LTD is a prominent entity within the biomedicine sector, operating out of Taipei, Taiwan. Since its establishment in 2012, the company has been at the forefront of developing innovative treatments for a wide range of medical conditions. Its expertise in biomedicine has led to the creation of numerous therapeutic products, particularly focusing on conditions such as diabetic foot ulcers, alopecia, various metabolic diseases, and more. Through rigorous clinical trials and research, Energenesis Biomedical seeks to address some of the most pressing health issues facing society today.

Products and Services

The company's diverse product portfolio includes:

• ENERGI-F703: Currently in Phase II clinical trial, this treatment is designed for diabetic foot ulcers, aiming to enhance healing processes and improve patient outcomes.
• ENERGI-F701: A topical tonic for alopecia that is in Phase II clinical trial, demonstrating the company's commitment to developing treatments for dermatological conditions.
• ENERGI-F711: A burn cream formulated to expedite the healing of burns, showcasing the company's expertise in topical treatments.
• ENERGI-F702: Aimed at treating metabolic diseases, this product reflects the company's focus on addressing complex chronic conditions.
• ENERGI-F704: Developed for the treatment of inflammatory bowel disease, illustrating the company's endeavors in gastrointestinal health.
• ENERGI-F708: An asthma treatment that highlights the company's dedication to improving respiratory health.
• ENERGI-F705: Aimed at Parkinson's disease control, this product represents the company's investment in neurodegenerative disease research.
• ENERGI-F707: For the treatment of mitochondria deficiency, showcasing the company's interest in cellular level solutions.
• ENERGI-F706: Designed to treat cachexia, it indicates the company's attention to cancer and chronic disease-related conditions.
• ENERGI-F709: A vaccine adjuvant, underscoring the company's contributions to enhancing the efficacy of vaccines.
• ENERGI-F710: Focused on blood phosphate control, this product is crucial for patients with kidney-related health issues.

Beyond therapeutic developments, Energenesis Biomedical CO.,LTD. also offers a range of scientific products including western blot, cell culture supplement, protein isolation and quantification kits, dyes, and buffer solutions. These products facilitate various research and development activities in the biomedicine field, making Energenesis a comprehensive player in the industry.